IKS Health Q1 FY27 Results
Inventurus Knowledge Solutions Limited (NSE: IKS), operating as IKS Health, announced its financial performance for the quarter ended 30 June 2026 (Q1 FY27). The company posted revenue of INR 8,936 million, representing a 20.7% year‑over‑year increase (approximately 21% YoY in INR terms and 12% YoY in USD). EBITDA rose to INR 2,949 million, equal to 33% of revenue and up 24% YoY. Profit after tax (PAT) reached INR 1,937 million, or 21.7% of revenue, marking a 27.8% YoY rise, while adjusted PAT grew 28% YoY to INR 2,153 million, or 24.1% of revenue.
The results were driven by continued client trust, operational efficiency, and scalability of the Care Enablement platform, which combines AI, agentic workflows and human expertise. The quarter also saw the acquisition of TruBridge, expanding IKS Health’s capabilities to serve a broader range of healthcare organizations, including rural and community health systems.
Recognition received during the quarter includes a U.S. patent for the proprietary Engagement Learning Engine that powers the MyCareHub patient access solution, the 2026 Dallas‑Fort Worth Titan 100 award for Titan CEO (Sachin K. Gupta), Best CFO & Finance Strategy Excellence Awards 2026 (Excellence in Investor Relations and Best CFO in Healthcare awarded to Nithya Balasubramanian), FE HR Awards 2026 for Excellence in Onboarding and Role Enablement, and the American Medical Group Association Distinguished Corporate Partner Award 2026.
Founded in 2006, IKS Health was listed on the National Stock Exchange of India and Bombay Stock Exchange on 19 December 2024 (NSE code IKS, BSE code 544309). The company’s platform aims to reduce administrative, clinical and operational burdens in healthcare, enabling clinicians to focus on care delivery.
Safe harbour: Certain statements regarding future growth are forward‑looking and subject to risks and uncertainties; actual results may differ materially.